104 related articles for article (PubMed ID: 26164036)
1. Passive targeting of phosphatiosomes increases rolipram delivery to the lungs for treatment of acute lung injury: An animal study.
Fang CL; Wen CJ; Aljuffali IA; Sung CT; Huang CL; Fang JY
J Control Release; 2015 Sep; 213():69-78. PubMed ID: 26164036
[TBL] [Abstract][Full Text] [Related]
2. Use of cilomilast-loaded phosphatiosomes to suppress neutrophilic inflammation for attenuating acute lung injury: the effect of nanovesicular surface charge.
Liu FC; Yu HP; Lin CY; Elzoghby AO; Hwang TL; Fang JY
J Nanobiotechnology; 2018 Mar; 16(1):35. PubMed ID: 29602314
[TBL] [Abstract][Full Text] [Related]
3. Intravenous anti-MRSA phosphatiosomes mediate enhanced affinity to pulmonary surfactants for effective treatment of infectious pneumonia.
Hsu CY; Sung CT; Aljuffali IA; Chen CH; Hu KY; Fang JY
Nanomedicine; 2018 Feb; 14(2):215-225. PubMed ID: 29128664
[TBL] [Abstract][Full Text] [Related]
4. Action of a Novel PDE4 inhibitor ZL-n-91 on lipopolysaccharide-induced acute lung injury.
Tang HF; Lu JJ; Tang JF; Zheng X; Liang YQ; Wang XF; Wang YJ; Mao LG; Chen JQ
Int Immunopharmacol; 2010 Apr; 10(4):406-11. PubMed ID: 20074667
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel loaded PEG(5000)-DSPE micelles as pulmonary delivery platform: formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation.
Gill KK; Nazzal S; Kaddoumi A
Eur J Pharm Biopharm; 2011 Oct; 79(2):276-84. PubMed ID: 21575719
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiological effects of intravenous phosphodiesterase type 4 inhibitor in addition to surfactant lavage in meconium-injured newborn piglet lungs.
Chen WY; Lin CH; Lee YS; Tsao PC; Jeng MJ
Pediatr Pulmonol; 2020 Sep; 55(9):2272-2282. PubMed ID: 32478966
[TBL] [Abstract][Full Text] [Related]
7. Chemopreventive effect of phosphodieasterase-4 inhibition in benzo(a)pyrene-induced murine lung cancer model.
Yeo CD; Kim JW; Ha JH; Kim SJ; Lee SH; Kim IK; Kim YK
Exp Lung Res; 2014 Dec; 40(10):500-6. PubMed ID: 25275945
[TBL] [Abstract][Full Text] [Related]
8. pH-Responsive Nanoparticles Targeted to Lungs for Improved Therapy of Acute Lung Inflammation/Injury.
Zhang CY; Lin W; Gao J; Shi X; Davaritouchaee M; Nielsen AE; Mancini RJ; Wang Z
ACS Appl Mater Interfaces; 2019 May; 11(18):16380-16390. PubMed ID: 30973702
[TBL] [Abstract][Full Text] [Related]
9.
Dhande R; Tyagi A; Sharma RK; Thakkar H
Pulm Pharmacol Ther; 2018 Apr; 49():36-45. PubMed ID: 29337265
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of chlorine-induced lung injury by the type 4 phosphodiesterase inhibitor rolipram.
Chang W; Chen J; Schlueter CF; Rando RJ; Pathak YV; Hoyle GW
Toxicol Appl Pharmacol; 2012 Sep; 263(2):251-8. PubMed ID: 22763362
[TBL] [Abstract][Full Text] [Related]
11. Suppression of acute lung injury in mice by an inhibitor of phosphodiesterase type 4.
Miotla JM; Teixeira MM; Hellewell PG
Am J Respir Cell Mol Biol; 1998 Mar; 18(3):411-20. PubMed ID: 9490659
[TBL] [Abstract][Full Text] [Related]
12. The PDE4 inhibitor roflumilast improves memory in rodents at non-emetic doses.
Vanmierlo T; Creemers P; Akkerman S; van Duinen M; Sambeth A; De Vry J; Uz T; Blokland A; Prickaerts J
Behav Brain Res; 2016 Apr; 303():26-33. PubMed ID: 26794595
[TBL] [Abstract][Full Text] [Related]
13. Nanostructured lipid carriers containing a high percentage of a Pluronic copolymer increase the biodistribution of novel PDE4 inhibitors for the treatment of traumatic hemorrhage.
Hsieh PW; Wen CJ; Yu HP; Aljuffali IA; Huang YH; Fang JY
J Biomed Nanotechnol; 2014 Aug; 10(8):1520-35. PubMed ID: 25016652
[TBL] [Abstract][Full Text] [Related]
14. Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery.
Zhang B; Zhang Y; Yu D
Oncol Rep; 2017 Feb; 37(2):937-944. PubMed ID: 27959442
[TBL] [Abstract][Full Text] [Related]
15. In vivo selective binding of (R)-[11C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues.
Kenk M; Greene M; Thackeray J; deKemp RA; Lortie M; Thorn S; Beanlands RS; DaSilva JN
Nucl Med Biol; 2007 Jan; 34(1):71-7. PubMed ID: 17210463
[TBL] [Abstract][Full Text] [Related]
16. The phosphodiesterase-4 inhibitor rolipram attenuates heroin-seeking behavior induced by cues or heroin priming in rats.
Lai M; Zhu H; Sun A; Zhuang D; Fu D; Chen W; Zhang HT; Zhou W
Int J Neuropsychopharmacol; 2014 Sep; 17(9):1397-407. PubMed ID: 24832929
[TBL] [Abstract][Full Text] [Related]
17. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles.
Tong SW; Xiang B; Dong DW; Qi XR
Int J Pharm; 2012 Sep; 434(1-2):413-9. PubMed ID: 22698861
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase type 4 inhibitor prevents acute lung injury induced by cardiopulmonary bypass in a rat model.
Hamamoto M; Suga M; Nakatani T; Takahashi Y; Sato Y; Inamori S; Yagihara T; Kitamura S
Eur J Cardiothorac Surg; 2004 May; 25(5):833-8. PubMed ID: 15082290
[TBL] [Abstract][Full Text] [Related]
19. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
[TBL] [Abstract][Full Text] [Related]
20. Administration of a specific inhibitor of neutrophil elastase attenuates pulmonary fibrosis after acute lung injury in mice.
Fujino N; Kubo H; Suzuki T; He M; Suzuki T; Yamada M; Takahashi T; Ota C; Yamaya M
Exp Lung Res; 2012 Feb; 38(1):28-36. PubMed ID: 22148910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
